purchased by the Victorian government. According to the state government, it will enable IDT Australia to develop the final product for mRNA vaccines, which may be used in COVID vaccines, to treat cancer and flu patients, and also paves way for a proposed experimental HIV vaccine.
According to the press release by the Victorian Government, “the machine can process nanoparticles into final liquid drug form, sterilize the product and fill vials with mRNA vaccines”. The new piece of equipment will initially produce more than 150 doses for phase 1 of the clinical studies, but it has the potential to significantly accelerate our progress toward the national goal of 70% vaccination coverage.
Minister Pulford released a statement about the company’s progress in vaccine production. He said…
